WELLESLEY HILLS, Mass., Jan. 28 /CNW/ -- Joseph F. Finn, Jr., CPA, the
Assignee for the Benefit of Creditors of ActivBiotics, today announced the
completion the sale of the Company's fixed assets for in excess of
$300,000 through an auction on January 24th. In addition, due to the high
volume of requests for due diligence materials from prospective buyers for the
purchase of the intellectual property, the Company has created an online
datasite that allows access to confidential information pertinent to each of
the three assets: Rifalazil, antibacterial NCEs, and superoxide dismutase
small molecule mimetics.
The sale of ActivBiotics' assets is conducted through an Assignment for
the Benefit of Creditors process. The bidding for the assets, which may be
purchased separately or in combination, will be conducted on March 14, 2008.
Any person interested in purchasing the assets or learning more about the
bidding process should contact Mr. Joseph F. Finn, Jr., CPA.
Bidding packages, which contain technical information and the terms of
sale, have been assembled and are ready to be distributed subject to a
potential purchaser entering into a standard form confidentiality agreement.
Request for Further Information
Interested parties can obtain a bidder's package by contacting Joseph F.
Finn, Jr., CPA (firstname.lastname@example.org, phone 781-237-8840), Finn, Warnke &
Gayton, 167 Worcester Street, Suite 201, Wellesley Hills, MA 02481-3613. For
technical information or questions regarding the products, please contact
Christo Shalish, email@example.com.
For further information:
For further information: Joseph F. Finn, Jr., CPA, (781) 237-8840,
firstname.lastname@example.org, for ActivBiotics; or Christo Shalish of ActivBiotics,
email@example.com; Web Site: http://www.activbiotics.com